Our research
Molecular Oncology
Professor Norris鈥檚 group utilises molecular genetic techniques to improve the diagnosis and risk classification of childhood cancers including leukaemia and neuroblastoma. A major area within the group is the use of functional genomics and high-throughput screening strategies to detect novel molecular targets and relevant inhibitors.
Contact: Professor Murray Norris
Leukaemia Biology
Leukaemia accounts for approximately one third of all paediatric malignancies and represents one of the most frequent causes of cancer-related deaths in children. The long-term goal of this group is to improve the treatment of children with leukaemia through the development of new therapies and their preclinical testing in clinically relevant experimental models.
Contact: Professor Richard Lock
Tumour Biology and Targeting
Dr Merlot leads a project in this group focused on (1) identifying drivers that cause resistance to cancer therapy, particularly the endoplasmic reticulum pathways; (2) understanding how the tumour microenvironment supports and protects cancer cells; and (3) developing and validating novel targets, drugs and drug delivery systems to treat the deadliest cancers, including pancreatic and brain cancer.
Contact: Dr Angelica Merlot
Contact us
For general enquiries and membership:
Dr Amanda Philp
Researcher Development & Strategy Manager
(02) 7209 6746